Shares in the pathology company jumped 6 per cent after it achieved a robust price for Lumus, which does MRI, X-rays and CT ...

Healius will be in a “material net cash position’’ following the sale of its Lumus Imaging division for $965m, and will ...

We recently compiled a list of the Jim Cramer Reveals 12 Stocks Investors Should Monitor Closely. In this article, we are ...

Healius has confirmed that it has sold its Lumus Imaging business to private equity firm Affinity Equity Partners, in a deal ...

The global anatomic pathology market was valued at approximately USD 35.17 billion in 2023 and is expected to expand at a compound annual growth rate (CAGR) of 8.2% from 2024 to 2032, surpassing USD ...

Healthcare services provider Healius has agreed to sell its Lumus Imaging subsidiary to funds managed by Asian private equity ...

Healius is set to become debt-free after selling its radiology business, Lumus Imaging, for $965 million, exceeding analyst ...

Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company for liver, metabolic and fibro-inflammatory diseases announced today that the ...

Healius Ltd. agreed to sell its Lumus imaging unit to a private equity group for A$965 million ($657 million), as the ...

Morgans analyst Derek Jellinek maintained a Hold rating on Healius Limited (PGZ – Research Report) today and set a price target of ...

Katharine Mitropoulos, an author and the founder of Set Sail Press LLC, hosted a book launch event for her second book, ...

GRM and HistoWiz expand their partnership, with HistoWiz now using GRM's pathology storage services for blocks and slides.